Publicaciones en colaboración con investigadores/as de Ospedale San Martino (188)

2023

  1. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 24, Núm. 1, pp. 77-90

  2. Clinical and angiographic features of SCAD type 4

    International Journal of Cardiology, Vol. 377, pp. 22-25

  3. Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry

    American Journal of Cardiology, Vol. 198, pp. 1-8

  4. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)

    Intensive Care Medicine

  5. Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT (Journal of Hematology & Oncology, (2023), 16, 1, (58), 10.1186/s13045-023-01450-4)

    Journal of Hematology and Oncology

  6. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    European Respiratory Journal, Vol. 61, Núm. 4

  7. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632

  8. Editorial: Personalized therapy in ARDS

    Frontiers in Medicine

  9. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

    The Lancet, Vol. 402, Núm. 10395, pp. 41-53

  10. Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

    Transplantation and Cellular Therapy, Vol. 29, Núm. 3, pp. 184.e1-184.e9

  11. Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence

    Geburtshilfe und Frauenheilkunde, Vol. 84, Núm. 2, pp. 164-184

  12. Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes

    Minerva cardiology and angiology, Vol. 71, Núm. 5, pp. 525-534

  13. Interventional Versus Conservative Strategy in Patients with Spontaneous Coronary Artery Dissections: Insights from DISCO Registry

    Circulation: Cardiovascular Interventions, Vol. 16, Núm. 6, pp. E012780

  14. Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study)

    Trials, Vol. 24, Núm. 1